Cargando…

Insulin-Like Growth Factor and Epidermal Growth Factor Signaling in Breast Cancer Cell Growth: Focus on Endocrine Resistant Disease

Breast cancer is the most common type of cancer for women worldwide with a lifetime risk amounting to a staggering total of 10%. It is well established that the endogenous synthesis of insulin-like growth factor (IGF) and epidermal growth factor (EGF) polypeptide growth factors are closely correlate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voudouri, Kallirroi, Berdiaki, Aikaterini, Tzardi, Maria, Tzanakakis, George N., Nikitovic, Dragana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518167/ https://www.ncbi.nlm.nih.gov/pubmed/26258011 http://dx.doi.org/10.1155/2015/975495

Ejemplares similares

The Motile Breast Cancer Phenotype Roles of Proteoglycans/Glycosaminoglycans
por: Nikitovic, Dragana, et al.
Publicado: (2014)

Data on the putative role of p53 in breast cancer cell adhesion: Technical information for adhesion assay
por: Voudouri, Kallirroi, et al.
Publicado: (2016)

Biglycan Interacts with Type I Insulin-like Receptor (IGF-IR) Signaling Pathway to Regulate Osteosarcoma Cell Growth and Response to Chemotherapy
por: Giatagana, Eirini-Maria, et al.
Publicado: (2022)

Heparin regulates B6FS cell motility through a FAK/actin cytoskeleton axis
por: Voudouri, Kallirroi, et al.
Publicado: (2016)

Cancer Microenvironment and Inflammation: Role of Hyaluronan
por: Nikitovic, Dragana, et al.
Publicado: (2015)

The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican
por: Berdiaki, Aikaterini, et al.
Publicado: (2023)

Biglycan Regulates MG63 Osteosarcoma Cell Growth Through a LPR6/β-Catenin/IGFR-IR Signaling Axis
por: Aggelidakis, John, et al.
Publicado: (2018)

Lumican mediates HTB94 chondrosarcoma cell growth via an IGF-IR/Erk1/2 axis
por: Papoutsidakis, Antonis, et al.
Publicado: (2020)

Lumican in Carcinogenesis—Revisited
por: Giatagana, Eirini-Maria, et al.
Publicado: (2021)

Proteoglycans—Biomarkers and Targets in Cancer Therapy
por: Nikitovic, Dragana, et al.
Publicado: (2018)

Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors
por: Tzanakakis, George, et al.
Publicado: (2020)

Parathyroid hormone/parathyroid hormone-related peptide regulate osteosarcoma cell functions: Focus on the extracellular matrix (Review)
por: Nikitovic, Dragana, et al.
Publicado: (2016)

Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy
por: Berdiaki, Aikaterini, et al.
Publicado: (2021)

The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis
por: Tzanakakis, George N., et al.
Publicado: (2021)

Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells
por: Li, Ping, et al.
Publicado: (2013)

Insulin-like growth factor binding protein 3 modulates epidermal growth factor (EGF)-induced growth of breast epithelial cells by altering EGF receptor internalization
por: Dennison, GJ, et al.
Publicado: (2008)

Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer
por: Amutha, Periyasamy, et al.
Publicado: (2017)

The Insulin-like Growth Factor System and Colorectal Cancer
por: Gligorijević, Nikola, et al.
Publicado: (2022)

Preface of the Special Issue on the Role of Extracellular Matrix in Development and Cancer Progression
por: Tzanakakis, George, et al.
Publicado: (2022)

Human epidermal growth factor receptor-2 and endocrine resistance in hormone-dependent breast cancer
por: Alataki, Anastasia, et al.
Publicado: (2022)

The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor
Publicado: (1992)

Expression of receptors for epidermal growth factor and insulin-like growth factor I by ZR-75-1 human breast cancer cell variants is inversely related: the effect of steroid hormones on insulin-like growth factor I receptor expression.
por: van den Berg, H. W., et al.
Publicado: (1996)

Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles as Carriers for Nonsteroidal, Anti-Inflammatory Drugs: Pharmacokinetic, Anti-Inflammatory, and Ulcerogenic Activity Study
por: Kuskov, Andrey, et al.
Publicado: (2022)

Epidermal Growth Factor Receptors and Breast Cancer
por: Farndon, J. R., et al.
Publicado: (1989)

Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function
por: Marshman, Emma, et al.
Publicado: (2002)

The Role of Insulin-Like Growth Factors and Insulin-Like Growth Factor–Binding Proteins in the Nervous System
por: Lewitt, Moira S, et al.
Publicado: (2019)

Characterization of a Drosophila protein that binds both epidermal growth factor and insulin-related growth factors
Publicado: (1987)

Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor.
por: Mellon, J. K., et al.
Publicado: (1996)

Expression and localization of epidermal growth factor, transforming growth factor-α and epidermal growth factor receptor in the canine testis
por: TAMADA, Hiromichi, et al.
Publicado: (2015)

The Insulin-Like Growth Factor System
por: Roith, Derek Le
Publicado: (2003)

Insulin-like growth factors and cancer.
por: Macaulay, V. M.
Publicado: (1992)

Dual inhibition of epidermal growth factor and insulin-like 1 growth factor receptors reduce intestinal adenoma burden in the Apc(min/+) mouse
por: Shaw, P H S, et al.
Publicado: (2011)

In silico interaction of insulin-like growth factor binding protein 3 with insulin-like growth factor 1
por: Jafari, Elham, et al.
Publicado: (2018)

Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma.
por: Filipe, M. I., et al.
Publicado: (1995)

Role of extracellular electrolytes in the activation of ribosomal protein S6 kinase by epidermal growth factor, insulin-like growth factor 1, and insulin in ZR-75-1 cells
Publicado: (1988)

Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in mice
por: Huang, Guangcun, et al.
Publicado: (2012)

Fibrogenic Effects of Heparin-Binding Epidermal Growth Factor-like Growth Factor: Myeloid or Epithelial Origin?
por: Martin, James G., et al.
Publicado: (2022)

Hyaluronan and Reactive Oxygen Species Signaling—Novel Cues from the Matrix?
por: Berdiaki, Aikaterini, et al.
Publicado: (2023)

The epidermal growth factor receptor family in breast cancer
por: Koutras, Angelos K, et al.
Publicado: (2008)

Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation
por: Tian, Dan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_drr945r0o8gp0guk2j8b5luru5